Merck Backs Alnylam’s RNAi Technology
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 40 (Table of Contents)
Published: 3 Oct-2003
DOI: 10.3833/pdr.v2003.i40.857 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Merck and Alnylam Holding entered into multiyear research collaboration to develop new drugs using Alnylam’s RNA interference (RNAi) Technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS